Heikki Irjala
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 25
- Immunology top 5%
- Oncology top 5%
- Lymphatic System and Diseases 8
- Cancer-related Molecular Pathways 6
- Immunology and Allergy top 5%
- Physiology top 5%
-
- Infectious Diseases and Tuberculosis 12
- Head and Neck Surgical Oncology 8
-
- Otolaryngology and Infectious Diseases 12
-
- Streptococcal Infections and Treatments 10
-
- Angiogenesis and VEGF in Cancer 7
- Co-authors
- Sirpa JalkanenMarko SalmiReidar GrénmanKalle AlanenCatharina SvanborgLaura AirasMaija SarasteLong Hang
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Heikki Irjala
71 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 121
- Otorhinolaryngology 232
- Immunology 742
- Oncology 678
- Immunology and Allergy 115
- Physiology 67
Countries citing papers authored by Heikki Irjala
This map shows the geographic impact of Heikki Irjala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heikki Irjala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heikki Irjala more than expected).
Fields of papers citing papers by Heikki Irjala
This network shows the impact of papers produced by Heikki Irjala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heikki Irjala. The network helps show where Heikki Irjala may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Heikki Irjala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 14 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 17 | |
| 12 | 2015 | 5 | |
| 13 | 2014 | 77 | |
| 14 | 2013 | 7 | |
| 15 | 2013 | 22 | |
| 16 | 2011 | 28 | |
| 17 | 2009 | 75 | |
| 18 | 2003 | 101 | |
| 19 | 2002 | 40 | |
| 20 | 2001 | 43 |
About Heikki Irjala
Heikki Irjala is a scholar working on Otorhinolaryngology, Oncology and Surgery, having authored 77 papers that have together received 2.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (25 papers), Infectious Diseases and Tuberculosis (12 papers), Otolaryngology and Infectious Diseases (12 papers), Streptococcal Infections and Treatments (10 papers), Lymphatic System and Diseases (8 papers), Head and Neck Surgical Oncology (8 papers), Angiogenesis and VEGF in Cancer (7 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Otorhinolaryngology (232 citations), Immunology (742 citations) and Oncology (678 citations). Heikki Irjala has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Sirpa Jalkanen, Marko Salmi, Reidar Grénman, Kalle Alanen, Catharina Svanborg, Laura Airas, Maija Saraste, Long Hang, Björn Wullt and Patrik Samuelsson. Their work appears in journals such as The Journal of Experimental Medicine, Blood and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.